Overview
Hiroki Ide practices in Tokyo, Japan. Mr. Ide is rated as a Distinguished expert by MediFind in the treatment of Upper Tract Urothelial Carcinoma (UTUC). His top areas of expertise are Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Nephrectomy, and Cystectomy.
His clinical research consists of co-authoring 68 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 13 articles in the study of Upper Tract Urothelial Carcinoma (UTUC).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Bladder CancerMr. Ide isElite. Learn about Bladder Cancer.
- Distinguished
- Upper Tract Urothelial Carcinoma (UTUC)
- Urothelial CancerMr. Ide isDistinguished. Learn about Urothelial Cancer.
- Advanced
- Enlarged Prostate (BPH)Mr. Ide isAdvanced. Learn about Enlarged Prostate (BPH).
- NephrectomyMr. Ide isAdvanced. Learn about Nephrectomy.
- Experienced
- CystectomyMr. Ide isExperienced. Learn about Cystectomy.
- HydronephrosisMr. Ide isExperienced. Learn about Hydronephrosis.
- Kidney TransplantMr. Ide isExperienced. Learn about Kidney Transplant.
- Prostate CancerMr. Ide isExperienced. Learn about Prostate Cancer.
- ProstatectomyMr. Ide isExperienced. Learn about Prostatectomy.
- Renal Cell Carcinoma (RCC)Mr. Ide isExperienced. Learn about Renal Cell Carcinoma (RCC).